secwatch.observer — SEC 8-K summary
======================================

Issuer:     Decoy Therapeutics Inc. (DCOY)
CIK:        0001615219
Form:       8-K
Filed at:   2026-01-02T23:59:59+00:00
Accession:  0001615219-26-000005
Event type: regulatory
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Salarius receives Nasdaq delisting notice for bid price non-compliance; appeal planned
--------------------------------------------------------------------------------

- Nasdaq notified Salarius on Dec 31, 2025 that bid price closed below $1.00 for 30 consecutive days.
- Company ineligible for 180-day cure period due to reverse stock split within prior year.
- Unless appeal filed by Jan 7, 2026, trading suspended Jan 9, 2026 and Form 25-NSE filed.
- Salarius intends to appeal to Nasdaq Hearings Panel to stay suspension and present compliance plan.
- No assurance that securities will remain listed on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1615219/000161521926000005/0001615219-26-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1615219/000161521926000005/flks-20251231.htm
  HTML page:      https://secwatch.observer/filing/0001615219-26-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer